Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne toothpaste.The ...
Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.
16don MSN
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.
Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...
Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...
Explore more
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's largest shareholder with over 5%.
Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated ...
I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results